These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


601 related items for PubMed ID: 12029139

  • 1. Induction of cachexia in mice by systemically administered myostatin.
    Zimmers TA, Davies MV, Koniaris LG, Haynes P, Esquela AF, Tomkinson KN, McPherron AC, Wolfman NM, Lee SJ.
    Science; 2002 May 24; 296(5572):1486-8. PubMed ID: 12029139
    [Abstract] [Full Text] [Related]

  • 2. Acute inhibition of myostatin-family proteins preserves skeletal muscle in mouse models of cancer cachexia.
    Benny Klimek ME, Aydogdu T, Link MJ, Pons M, Koniaris LG, Zimmers TA.
    Biochem Biophys Res Commun; 2010 Jan 15; 391(3):1548-54. PubMed ID: 20036643
    [Abstract] [Full Text] [Related]

  • 3. The possible role of myostatin in skeletal muscle atrophy and cachexia.
    Jespersen J, Kjaer M, Schjerling P.
    Scand J Med Sci Sports; 2006 Apr 15; 16(2):74-82. PubMed ID: 16533345
    [Abstract] [Full Text] [Related]

  • 4. Follistatin-derived peptide expression in muscle decreases adipose tissue mass and prevents hepatic steatosis.
    Nakatani M, Kokubo M, Ohsawa Y, Sunada Y, Tsuchida K.
    Am J Physiol Endocrinol Metab; 2011 Mar 15; 300(3):E543-53. PubMed ID: 21205933
    [Abstract] [Full Text] [Related]

  • 5. Myostatin DNA vaccine increases skeletal muscle mass and endurance in mice.
    Tang L, Yan Z, Wan Y, Han W, Zhang Y.
    Muscle Nerve; 2007 Sep 15; 36(3):342-8. PubMed ID: 17587222
    [Abstract] [Full Text] [Related]

  • 6. Postnatal expression of myostatin propeptide cDNA maintained high muscle growth and normal adipose tissue mass in transgenic mice fed a high-fat diet.
    Yang J, Zhao B.
    Mol Reprod Dev; 2006 Apr 15; 73(4):462-9. PubMed ID: 16437538
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Mechanisms to explain wasting of muscle and fat in cancer cachexia.
    Argilés JM, López-Soriano FJ, Busquets S.
    Curr Opin Support Palliat Care; 2007 Dec 15; 1(4):293-8. PubMed ID: 18685378
    [Abstract] [Full Text] [Related]

  • 9. Functional improvement of dystrophic muscle by myostatin blockade.
    Bogdanovich S, Krag TO, Barton ER, Morris LD, Whittemore LA, Ahima RS, Khurana TS.
    Nature; 2002 Nov 28; 420(6914):418-21. PubMed ID: 12459784
    [Abstract] [Full Text] [Related]

  • 10. Transgenic expression of myostatin propeptide prevents diet-induced obesity and insulin resistance.
    Zhao B, Wall RJ, Yang J.
    Biochem Biophys Res Commun; 2005 Nov 11; 337(1):248-55. PubMed ID: 16182246
    [Abstract] [Full Text] [Related]

  • 11. Embryonic overexpression of Galgt2 inhibits skeletal muscle growth via activation of myostatin signaling.
    Chandraskeharan K, Martin PT.
    Muscle Nerve; 2009 Jan 11; 39(1):25-41. PubMed ID: 19086062
    [Abstract] [Full Text] [Related]

  • 12. Regulation of muscle mass by myostatin.
    Lee SJ.
    Annu Rev Cell Dev Biol; 2004 Jan 11; 20():61-86. PubMed ID: 15473835
    [Abstract] [Full Text] [Related]

  • 13. Bone mineral content and density in the humerus of adult myostatin-deficient mice.
    Hamrick MW, McPherron AC, Lovejoy CO.
    Calcif Tissue Int; 2002 Jul 11; 71(1):63-8. PubMed ID: 12060865
    [Abstract] [Full Text] [Related]

  • 14. Muscle-bone interactions in dystrophin-deficient and myostatin-deficient mice.
    Montgomery E, Pennington C, Isales CM, Hamrick MW.
    Anat Rec A Discov Mol Cell Evol Biol; 2005 Sep 11; 286(1):814-22. PubMed ID: 16078270
    [Abstract] [Full Text] [Related]

  • 15. A missense mutant myostatin causes hyperplasia without hypertrophy in the mouse muscle.
    Nishi M, Yasue A, Nishimatu S, Nohno T, Yamaoka T, Itakura M, Moriyama K, Ohuchi H, Noji S.
    Biochem Biophys Res Commun; 2002 Apr 26; 293(1):247-51. PubMed ID: 12054591
    [Abstract] [Full Text] [Related]

  • 16. Myostatin antisense RNA-mediated muscle growth in normal and cancer cachexia mice.
    Liu CM, Yang Z, Liu CW, Wang R, Tien P, Dale R, Sun LQ.
    Gene Ther; 2008 Feb 26; 15(3):155-60. PubMed ID: 18033313
    [Abstract] [Full Text] [Related]

  • 17. Targeting myostatin for therapies against muscle-wasting disorders.
    Tsuchida K.
    Curr Opin Drug Discov Devel; 2008 Jul 26; 11(4):487-94. PubMed ID: 18600566
    [Abstract] [Full Text] [Related]

  • 18. Effects of CRF2R agonist on tumor growth and cachexia in mice implanted with Lewis lung carcinoma cells.
    Argilés JM, Figueras M, Ametller E, Fuster G, Olivan M, de Oliveira CC, López-Soriano FJ, Isfort RJ, Busquets S.
    Muscle Nerve; 2008 Feb 26; 37(2):190-5. PubMed ID: 17912749
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 31.